Teleflex Incorporated $TFX Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue cut its position in shares of Teleflex Incorporated (NYSE:TFX) by 58.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,148 shares of the medical technology company’s stock after selling 10,066 shares during the period. State of Alaska Department of Revenue’s holdings in Teleflex were worth $893,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Kelleher Financial Advisors bought a new stake in Teleflex in the 2nd quarter worth approximately $25,000. Allworth Financial LP bought a new position in shares of Teleflex during the 2nd quarter valued at approximately $44,000. Versant Capital Management Inc boosted its position in shares of Teleflex by 573.4% during the 2nd quarter. Versant Capital Management Inc now owns 431 shares of the medical technology company’s stock valued at $55,000 after acquiring an additional 367 shares during the last quarter. Trust Co. of Vermont bought a new position in shares of Teleflex during the 2nd quarter valued at approximately $57,000. Finally, Integrated Wealth Concepts LLC bought a new position in shares of Teleflex during the 2nd quarter valued at approximately $57,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 0.5%

NYSE:TFX opened at $130.47 on Thursday. The company has a market cap of $5.53 billion, a price-to-earnings ratio of -5.60, a price-to-earnings-growth ratio of 0.88 and a beta of 0.83. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $145.00. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. The stock has a fifty day simple moving average of $130.95 and a 200-day simple moving average of $130.62.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The firm had revenue of $570.33 million for the quarter, compared to analysts’ expectations of $559.59 million. During the same period in the prior year, the business posted $3.73 earnings per share. The business’s revenue for the quarter was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Analysts anticipate that Teleflex Incorporated will post 7.22 EPS for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.84%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. UBS Group boosted their price target on shares of Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 11th. Bank of America raised shares of Teleflex from a “neutral” rating to a “buy” rating and upped their price target for the company from $145.00 to $158.00 in a research note on Monday, September 28th. Needham & Company LLC increased their price objective on shares of Teleflex from $159.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, August 25th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Monday, September 21st. Finally, BMO Capital Markets started coverage on shares of Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $154.40.

Teleflex Profile

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.